Dennis J. Slamon's most recent trade in Biomarin Pharmaceutical Inc. - Registered Shares was a trade of 10,000 Common Stock done at an average price of $79.7 . Disclosure was reported to the exchange on March 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biomarin pharma Inc - Registered Shares | Dennis J. Slamon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.70 per share. | 18 Mar 2024 | 10,000 | 40,809 (0%) | 0% | 79.7 | 797,000 | Common Stock |
| Biomarin pharma Inc - Registered Shares | Dennis J. Slamon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2024 | 10,000 | 0 | - | - | Stock Option (Right to Buy Common Stock) | |
| Biomarin pharma Inc - Registered Shares | Dennis J. Slamon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.81 per share. | 18 Mar 2024 | 9,510 | 31,299 (0%) | 0% | 83.8 | 797,033 | Common Stock |
| Biomarin pharma Inc - Registered Shares | Dennis J. Slamon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 4,190 | 30,809 (0%) | 0% | 0 | Common Stock | |
| Biomarin pharma Inc - Registered Shares | Dennis J. Slamon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 4,980 | 26,619 (0%) | 0% | 0 | Common Stock | |
| Biomarin pharma Inc - Registered Shares | Dennis J. Slamon | Director | Sale of securities on an exchange or to another person at price $ 78.33 per share. | 28 Feb 2022 | 5,815 | 22,220 (0%) | 0% | 78.3 | 455,489 | Common Stock |
| Biomarin pharma Inc - Registered Shares | Dennis J. Slamon | Director | Sale of securities on an exchange or to another person at price $ 78.35 per share. | 28 Feb 2022 | 214 | 21,961 (0%) | 0% | 78.4 | 16,767 | Common Stock |
| Biomarin pharma Inc - Registered Shares | Dennis J. Slamon | Director | Sale of securities on an exchange or to another person at price $ 78.36 per share. | 28 Feb 2022 | 122 | 21,739 (0%) | 0% | 78.4 | 9,560 | Common Stock |
| Biomarin pharma Inc - Registered Shares | Dennis J. Slamon | Director | Sale of securities on an exchange or to another person at price $ 78.37 per share. | 28 Feb 2022 | 100 | 21,639 (0%) | 0% | 78.4 | 7,837 | Common Stock |
| Biomarin pharma Inc - Registered Shares | Dennis J. Slamon | Director | Sale of securities on an exchange or to another person at price $ 78.35 per share. | 28 Feb 2022 | 100 | 21,861 (0%) | 0% | 78.4 | 7,835 | Common Stock |
| Biomarin pharma Inc - Registered Shares | Dennis J. Slamon | Director | Sale of securities on an exchange or to another person at price $ 78.33 per share. | 28 Feb 2022 | 45 | 22,175 (0%) | 0% | 78.3 | 3,525 | Common Stock |
| Biomarin pharma Inc - Registered Shares | Dennis J. Slamon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 5,120 | 28,035 (0%) | 0% | 0 | Common Stock |